Back
NRX Pharmaceuticals Vs. CEL-SCI Industry Stock Comparison
Sell
45
NRXP
NRX Pharmaceuticals
Last Price:
1.26
Seasonality Move:
44.75%
Sell
38
CVM
CEL-SCI
Last Price:
0.60
Seasonality Move:
22.5%
Sell
45
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy, Sell or Hold?
- The current NRX Pharmaceuticals [NRXP] share price is $1.26. The Score for NRXP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NRXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
CEL-SCI (CVM)
is a Sell
Is CEL-SCI a Buy, Sell or Hold?
- The current CEL-SCI [CVM] share price is $0.60. The Score for CVM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRXP Stock Price Chart
What is NRX Pharmaceuticals's stock price today?
-
The NRX Pharmaceuticals share price today is $1.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NRXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.49 | Sell |
| Chaikin Money Flow: | 51053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.33) | Sell |
| Bollinger Bands (100): | (1.33 - 2.15) | Sell |
CVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 27.92 | Sell |
| Chaikin Money Flow: | 89257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.63 - 0.89) | Sell |
| Bollinger Bands (100): | (0.84 - 1.26) | Sell |
NRXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Buy |
| 20-day SMA: | 1.28 | Sell |
| 50-day SMA: | 1.4 | Sell |
| 200-day SMA: | 2.88 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.27 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 2.62 | Sell |
CVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Sell |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 0.92 | Sell |
| 200-day SMA: | 1.36 | Sell |
| 8-day EMA: | 0.62 | Sell |
| 20-day EMA: | 0.71 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.31 | Sell |
NRX Pharmaceuticals Earnings Growth & NRXP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $1.17 per share.
CEL-SCI Earnings Growth & CVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.18 per share.
NRX Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CEL-SCI Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||